Correlation Between 67401PAC2 and Aquestive Therapeutics
Specify exactly 2 symbols:
By analyzing existing cross correlation between OCSL 27 15 JAN 27 and Aquestive Therapeutics, you can compare the effects of market volatilities on 67401PAC2 and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 67401PAC2 with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 67401PAC2 and Aquestive Therapeutics.
Diversification Opportunities for 67401PAC2 and Aquestive Therapeutics
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between 67401PAC2 and Aquestive is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding OCSL 27 15 JAN 27 and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and 67401PAC2 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OCSL 27 15 JAN 27 are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of 67401PAC2 i.e., 67401PAC2 and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between 67401PAC2 and Aquestive Therapeutics
Assuming the 90 days trading horizon 67401PAC2 is expected to generate 1870.0 times less return on investment than Aquestive Therapeutics. But when comparing it to its historical volatility, OCSL 27 15 JAN 27 is 5.07 times less risky than Aquestive Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Aquestive Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 160.00 in Aquestive Therapeutics on September 12, 2024 and sell it today you would earn a total of 222.00 from holding Aquestive Therapeutics or generate 138.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 98.3% |
| Values | Daily Returns |
OCSL 27 15 JAN 27 vs. Aquestive Therapeutics
Performance |
| Timeline |
| OCSL 27 15 |
| Aquestive Therapeutics |
67401PAC2 and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 67401PAC2 and Aquestive Therapeutics
The main advantage of trading using opposite 67401PAC2 and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 67401PAC2 position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.| 67401PAC2 vs. Aquestive Therapeutics | 67401PAC2 vs. Allegheny Technologies Incorporated | 67401PAC2 vs. Algoma Steel Group | 67401PAC2 vs. LENSAR Inc |
| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stocks Directory Find actively traded stocks across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |